Teladoc Inc (NYSE:TDOC) shares reached a new 52-week high on Monday after SunTrust Banks raised their price target on the stock to $100.00. SunTrust Banks currently has a buy rating on the stock. Teladoc traded as high as $81.05 and last traded at $77.95, with a volume of 66452 shares changing hands. The stock had previously closed at $78.15.
Several other analysts have also commented on the stock. Piper Jaffray Companies lifted their price objective on shares of Teladoc to $84.00 and gave the stock an “overweight” rating in a research report on Friday, September 21st. TheStreet raised shares of Teladoc from a “d+” rating to a “c” rating in a research report on Wednesday, August 22nd. Canaccord Genuity lifted their price objective on shares of Teladoc from $70.00 to $86.00 and gave the stock a “buy” rating in a research report on Thursday, September 20th. Citigroup lifted their price objective on shares of Teladoc from $80.00 to $88.00 and gave the stock a “buy” rating in a research report on Friday, September 21st. Finally, KeyCorp lifted their price objective on shares of Teladoc from $74.00 to $90.00 and gave the stock an “overweight” rating in a research report on Monday, August 27th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the stock. Teladoc has an average rating of “Buy” and a consensus target price of $67.80.
In other news, insider Lewis Levy sold 1,284 shares of Teladoc stock in a transaction dated Monday, September 17th. The shares were sold at an average price of $77.00, for a total value of $98,868.00. Following the completion of the transaction, the insider now owns 1,284 shares in the company, valued at $98,868. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Adam C. Vandervoort sold 5,550 shares of Teladoc stock in a transaction dated Monday, September 10th. The stock was sold at an average price of $77.67, for a total transaction of $431,068.50. Following the completion of the transaction, the insider now owns 2,934 shares of the company’s stock, valued at approximately $227,883.78. The disclosure for this sale can be found here. Insiders sold 286,781 shares of company stock valued at $19,429,607 in the last quarter. Corporate insiders own 3.95% of the company’s stock.
The company has a market cap of $5.43 billion, a P/E ratio of -49.09 and a beta of 0.57. The company has a current ratio of 3.14, a quick ratio of 3.14 and a debt-to-equity ratio of 0.58.
Teladoc (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, August 1st. The health services provider reported ($0.37) EPS for the quarter, beating the consensus estimate of ($0.38) by $0.01. The company had revenue of $94.60 million during the quarter, compared to analysts’ expectations of $91.56 million. Teladoc had a negative net margin of 37.78% and a negative return on equity of 19.10%. Teladoc’s revenue for the quarter was up 112.1% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.28) earnings per share. analysts predict that Teladoc Inc will post -1.51 earnings per share for the current fiscal year.
About Teladoc (NYSE:TDOC)
Teladoc, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
See Also: NASDAQ Stock Market Explained
Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.